DC cocultured with UVM cells showed reduced expression of CD1a and CD83, which failed to activate T cells for immune response, revealing the possibility of tumor-pulsed dendritic cell vaccines as therapeutic measures for UVM (78). This evidence concerns the gene CD83 and neoplasm.